Literature DB >> 11139609

The transcriptional program of a human B cell line in response to Myc.

M Schuhmacher1, F Kohlhuber, M Hölzel, C Kaiser, H Burtscher, M Jarsch, G W Bornkamm, G Laux, A Polack, U H Weidle, D Eick.   

Abstract

The proto-oncogene c-myc (myc) encodes a transcription factor (Myc) that promotes growth, proliferation and apoptosis. Myc has been suggested to induce these effects by induction/repression of downstream genes. Here we report the identification of potential Myc target genes in a human B cell line that grows and proliferates depending on conditional myc expression. Oligonucleotide microarrays were applied to identify downstream genes of Myc at the level of cytoplasmic mRNA. In addition, we identified potential Myc target genes in nuclear run-on experiments by changes in their transcription rate. The identified genes belong to gene classes whose products are involved in amino acid/protein synthesis, lipid metabolism, protein turnover/folding, nucleotide/DNA synthesis, transport, nucleolus function/RNA binding, transcription and splicing, oxidative stress and signal transduction. The identified targets support our current view that myc acts as a master gene for growth control and increases transcription of a large variety of genes.

Entities:  

Mesh:

Year:  2001        PMID: 11139609      PMCID: PMC29676          DOI: 10.1093/nar/29.2.397

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.

Authors:  M K Mateyak; A J Obaya; S Adachi; J M Sedivy
Journal:  Cell Growth Differ       Date:  1997-10

2.  c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets.

Authors:  A Bush; M Mateyak; K Dugan; A Obaya; S Adachi; J Sedivy; M Cole
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

3.  Coordination of growth and cell division in the Drosophila wing.

Authors:  T P Neufeld; A F de la Cruz; L A Johnston; B A Edgar
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

Review 4.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  The c-erbA alpha protooncogene induces apoptosis in glial cells via a protein kinase C- and bcl-2-suppressible mechanism.

Authors:  S Llanos; C Caelles; I Azorín; J Renau-Piqueras; J L Fernández-Luna; L Boscá; A Muñoz
Journal:  J Neurochem       Date:  1998-06       Impact factor: 5.372

6.  Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc.

Authors:  I B Rosenwald; D B Rhoads; L D Callanan; K J Isselbacher; E V Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Authors:  A Bauer; W Mikulits; G Lagger; G Stengl; G Brosch; H Beug
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

8.  A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

Authors:  Y Izumi; M Hirata; H Hasuwa; R Iwamoto; T Umata; K Miyado; Y Tamai; T Kurisaki; A Sehara-Fujisawa; S Ohno; E Mekada
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

9.  Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.

Authors:  L Mastroberardino; B Spindler; R Pfeiffer; P J Skelly; J Loffing; C B Shoemaker; F Verrey
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

10.  c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene.

Authors:  O Gandrillon; N Ferrand; J J Michaille; L Roze; M H Zile; J Samarut
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

View more
  148 in total

1.  MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.

Authors:  Martin S Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria G Masucci; Axel Polack; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 2.  Disentangling the MYC web.

Authors:  David Levens
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

3.  Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius.

Authors:  P E Neiman; A Ruddell; C Jasoni; G Loring; S J Thomas; K A Brandvold; J Burnside; J Delrow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

4.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.

Authors:  Izidore S Lossos; Ash A Alizadeh; Maximilian Diehn; Roger Warnke; Yvonne Thorstenson; Peter J Oefner; Patrick O Brown; David Botstein; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

Review 5.  Microarray-based expression profiling of normal and malignant immune cells.

Authors:  Rheem D Medh
Journal:  Endocr Rev       Date:  2002-06       Impact factor: 19.871

6.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin.

Authors:  Scott R Frank; Tiziana Parisi; Stefan Taubert; Paula Fernandez; Miriam Fuchs; Ho-Man Chan; David M Livingston; Bruno Amati
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

7.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 8.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 9.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

10.  Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer.

Authors:  Takeshi Shimamura; Zhao Chen; Margaret Soucheray; Julian Carretero; Eiki Kikuchi; Jeremy H Tchaicha; Yandi Gao; Katherine A Cheng; Travis J Cohoon; Jun Qi; Esra Akbay; Alec C Kimmelman; Andrew L Kung; James E Bradner; Kwok-Kin Wong
Journal:  Clin Cancer Res       Date:  2013-09-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.